Sofinnova-Investments

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
62
Total Value
1486841997
Accession Number
0001104659-25-049266
Form Type
13F-HR
Manager Name
Sofinnova-Investments
Data Enrichment
97% identified
60 identified2 unidentified

Holdings

62 positions
Manager:
Search and click to pin securities to the top
Page 2 of 4
Blueprint Medicines Corp
Shares:261.0K
Value:$23.1M
BRISTOL MYERS SQUIBB CO
Shares:371.5K
Value:$22.7M
INCYTE CORP
Shares:357.8K
Value:$21.7M
ANAPTYSBIO, INC
Shares:1.2M
Value:$21.6M
Sarepta Therapeutics, Inc.
Shares:327.6K
Value:$20.9M
Akero Therapeutics, Inc.
Shares:510.0K
Value:$20.6M
Axsome Therapeutics, Inc.
Shares:175.3K
Value:$20.4M
Rapport Therapeutics, Inc.
Shares:2.0M
Value:$20.0M
SUPERNUS PHARMACEUTICALS, INC.
Shares:520.7K
Value:$17.1M
Savara Inc
Shares:5.5M
Value:$15.2M
Cogent Biosciences, Inc.
Shares:2.2M
Value:$13.1M
Roivant Sciences Ltd.
Shares:1.3M
Value:$12.9M
DANAHER CORP /DE/
Shares:58.6K
Value:$12.0M
Penumbra Inc
Shares:42.9K
Value:$11.5M
Avidity Biosciences, Inc.
Shares:379.9K
Value:$11.2M
Inhibrx Biosciences, Inc.
Shares:697.9K
Value:$9.8M
Y-mAbs Therapeutics, Inc.
Shares:2.2M
Value:$9.7M
008064107
Shares:3.8M
Value:$9.4M
Pharvaris N.V.
Shares:593.4K
Value:$9.3M
BioAge Labs, Inc.
Shares:2.3M
Value:$8.7M